CMB International Investment Management Limited sold 1.15 million shares of BIOCYTOGEN-B stock at an average of HKD 54.6372 per share on September 1, 2026, involving about HKD 62.75 million.

Prior to the disposal, CMB International Investment Management Limited's long position in BIOCYTOGEN-B was 12.13 million shares, representing 10.95%; following the disposal, the holding changed to 10.98 million shares, with the long position ratio falling to 9.91%.